气喘预警感测器市场 - 全球产业规模、份额、趋势、机会及预测（按类型、技术、测量参数、最终用户、地区和竞争格局划分，2021-2031年）

全球气喘预警感测器市场预计将从 2025 年的 125.5 亿美元成长到 2031 年的 219.2 亿美元，年复合成长率为 9.74%。

这些电子监测系统旨在检测环境因素和生理变化，并在气喘即将发作时向使用者发出警报。推动这一增长的关键因素包括全球慢性呼吸系统疾病发病率的上升，以及远端患者监护工具与医疗保健基础设施的深度整合。此外，都市区日益严重的空气污染也促使人们需要能够帮助主动管理病情并最大限度减少紧急就医的个人健康设备。

然而，医疗设备市场面临许多重大障碍，例如严格的监管合规标准，这些标准延长了产品开发週期，并增加了生产商和最终用户的成本。这种监管负担常常阻碍创新技术在最需要的地区的应用。近期的数据凸显了这些健康和环境监测解决方案的迫切性：根据美国肺臟协会2024年的报告，美国有1.312亿人居住在空气污染严重的地区。

市场驱动因素

全球气喘和呼吸系统疾病发生率的不断上升是推动气喘预警感测器广泛应用的主要因素。国际诊断率的上升迫使医疗卫生系统实施有效的管理策略，以避免严重气喘发作和住院治疗，从而推动了对具备早期预警功能的连续监测设备的需求。例如，世界卫生组织（WHO）在2024年5月指出，全球约有2.62亿人患有气喘，显示此类技术拥有庞大的市场。此外，未治疗气喘带来的巨大经济负担也促使人们寻求经济有效的解决方案。美国气喘和过敏基金会（AAFA）在2024年3月报告称，美国每年因气喘造成的经济损失超过820亿美元，凸显了对先进预防工具的迫切需求。

物联网整合和穿戴式感测器技术的快速发展正在重塑市场格局，提升设备效能并提高用户依从性。现代感测器通常能够即时追踪药物使用情况，并与行动应用程式无缝同步，使患者和临床医生能够监测环境因素和治疗效果。这些技术进步支持远端监测，并透过促进严格的用药依从性和实现及时护理，显着改善了临床疗效。 2024 年发表在《气喘杂誌》（Journal of Asthma）上的一项研究发现，使用智慧吸入器技术的重度气喘患者的症状控制显着改善，其气喘控制调查问卷（ACQ-6）评分从基准的 2.81 分降至随访时的 1.92 分。这项已证实的效用正在加速将连网设备纳入标准呼吸系统疾病通讯协定。

市场挑战

严格的监管合规性对全球气喘预警感测器市场的成长构成重大障碍。由于这些设备越来越依赖临床级监测和预测演算法，它们通常被归类为医疗设备而非普通家用电子电器产品，并须接受全球卫生机构严格的安全检验、测试和资料隐私要求。管理这些复杂的核准流程需要耗费大量资源，迫使製造商延长研发週期，最终延缓尖端感测技术的商业性化应用。因此，这些高准入门槛阻碍了小规模创新者的进入，并减缓了整个产业的技术进步速度。

这些监管要求带来的营运和财务压力巨大且可衡量。製造商被迫投入大量资金用于认证和合规，挤占了原本可用于研发的资金，使得推出新型感测器的成本高得令人望而却步。据欧洲医疗技术协会（MedTech Europe）称，到2024年，医疗设备认证和维护成本将比上一指令增加高达100%，导致33%的领先製造商放弃选择该地区作为其首款产品上市地。这些成本的增加和由此造成的延误限制了患者获得气喘管理所需工具的机会，并阻碍了市场对日益恶化的环境因素做出快速反应的能力。

市场趋势

人工智慧驱动的预测分析技术的整合正在将全球气喘预警感测器市场从被动的警报系统转变为主动的预测工具。透过分析环境因素和电子健康记录等复杂资料来源，先进的演算法可以在出现身体症状之前很久就检测到气喘发作风险。这种转变使医疗服务提供者能够早期疗育，避免严重气喘发作，从而优化医疗系统资源。近期研究也证实了这些模型的临床有效性。根据2025年5月发表在《EClinicalMedicine》杂誌上的一项研究，一种基于人工智慧的新型被动式数位标记的曲线下面积（AUC）达到了0.79，这一预测准确性指标显着优于传统的风险评估方法。

同时，基于智慧型手机的声学喘鸣分析技术的兴起，使得无需专用设备，仅需使用标准行动麦克风即可进行客观评估，从而拓展了市场。该技术透过评估呼吸音和音频生物标记来识别气道阻塞，为患者提供了一种便捷、非侵入性的替代峰值流量计和肺功能仪的检测方法。使用常见的家用电子电器即可进行临床层级的评估，降低了先进监测解决方案的进入门槛。这些声学诊断工具的诊断准确性得到了可靠数据的支持。 2025年3月发表在《医疗保健》（Healthcare）杂誌上的一项研究报告称，一种分析特定音频音素的机器学习模型在判断气喘状态方面达到了98.7%的分类准确率。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

5. 全球气喘预警感测器市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（可穿戴/不可穿戴）
  • 按技术（人工智慧、物联网、机器学习等）
  • 透过测量参数（FEV1 与峰值流速）
  • 按最终用户划分（医院/诊所 vs.居家医疗）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美气喘预警感测器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲气喘预警感测器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区气喘预警感测器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲气喘预警感测器市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲气喘预警感测器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球气喘预警感测器市场：SWOT分析

第十四章 波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Philips Healthcare
• ResMed Inc.
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc
• Novartis AG
• AstraZeneca plc
• Merck & Co., Inc.
• Propeller Health
• Adherium Limited
• Cohero Health, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Asthma Warning Sensors Market is projected to expand from USD 12.55 Billion in 2025 to USD 21.92 Billion by 2031, reflecting a compound annual growth rate of 9.74%. These electronic monitoring systems are engineered to identify environmental triggers or physiological shifts, thereby alerting users to impending asthma attacks. Key factors propelling this growth include the rising worldwide incidence of chronic respiratory conditions and the deeper integration of remote patient monitoring tools into healthcare infrastructures. Furthermore, worsening air pollution in urban areas is fueling the need for personal health devices that support proactive management and help minimize emergency hospital visits.

However, the market faces a substantial hurdle in the form of rigorous regulatory compliance standards for medical devices, which extends product development timelines and inflates costs for both producers and end-users. This regulatory burden frequently postpones the arrival of innovative technologies in regions where they are most critically needed. The urgency for these health and environmental monitoring solutions is underscored by recent data; according to the American Lung Association's 2024 report, 131.2 million individuals in the United States resided in locations plagued by unhealthy air pollution levels.

Market Driver

The escalating global incidence of asthma and respiratory disorders acts as a major driver for the broad adoption of asthma warning sensors. As diagnosis rates climb internationally, health systems are under mounting pressure to deploy effective management strategies that avert severe flare-ups and hospital stays, leading to higher demand for continuous monitoring devices with early warning features. For example, the World Health Organization highlighted in May 2024 that asthma impacts roughly 262 million individuals globally, establishing a massive market for these technologies. Additionally, the significant financial strain of untreated conditions drives the need for cost-efficient solutions; the Asthma and Allergy Foundation of America reported in March 2024 that asthma's annual economic cost to the U.S. surpassed $82 billion, highlighting the financial necessity for advanced preventive tools.

Rapid progress in IoT integration and wearable sensor technology is reshaping the market by upgrading device capabilities and boosting user adherence. Contemporary sensors now frequently track medication use in real-time and synchronize seamlessly with mobile apps, enabling patients and clinicians to monitor environmental triggers and treatment success. These technical enhancements support remote monitoring and significantly better clinical results by promoting strict medication adherence and facilitating prompt care. A 2024 study in the Journal of Asthma revealed that severe asthma patients using smart inhaler technology saw marked improvements in control, with Asthma Control Questionnaire (ACQ-6) scores dropping from a baseline of 2.81 to 1.92 at follow-up, a proven utility that accelerates the adoption of connected devices in standard respiratory protocols.

Market Challenge

Rigorous regulatory compliance represents a significant obstacle to the growth of the Global Asthma Warning Sensors Market. Because these devices increasingly rely on clinical-grade monitoring and predictive algorithms, they are often categorized as medical devices rather than standard consumer electronics, subjecting them to stringent safety validation, testing, and data privacy mandates from global health authorities. The substantial resources needed to manage these complicated approval processes force manufacturers to extend development timelines, effectively delaying the commercial release of cutting-edge sensing technologies. Consequently, these high entry barriers deter smaller innovators and reduce the overall speed of technological progress within the industry.

The operational and financial pressure caused by these regulatory requirements is both severe and measurable. Manufacturers are compelled to direct substantial capital toward certification and compliance, diverting funds that could otherwise support research and development, making the cost of launching new sensors prohibitive. According to MedTech Europe, certification and maintenance expenses for medical devices rose by up to 100% in 2024 compared to earlier directives, resulting in a 33% reduction in major manufacturers choosing the region for initial product launches. These increased costs and subsequent delays restrict patient access to essential asthma management tools and hinder the market's capacity to react quickly to worsening environmental factors.

Market Trends

The integration of AI-powered predictive analytics is transforming the Global Asthma Warning Sensors Market from reactive alerting systems into proactive forecasting tools. By analyzing complex data sources like environmental variables and electronic health records, advanced algorithms can detect the risk of exacerbations well before physical symptoms manifest. This shift enables healthcare providers to execute early interventions that avert severe attacks, thereby optimizing health system resource usage. Recent research validates the clinical power of these models; a May 2025 study in EClinicalMedicine noted that a new AI-based passive digital marker achieved a prognostic accuracy Area Under the Curve (AUC) of 0.79, significantly surpassing traditional risk assessment methods.

Concurrently, the rise of smartphone-based acoustic wheeze analysis is broadening market reach by using standard mobile microphones for objective assessment, removing the need for dedicated hardware. This technology evaluates respiratory sounds and vocal biomarkers to identify airway obstruction, providing patients with a convenient, non-invasive substitute for peak flow meters or spirometry. The capacity to conduct clinical-grade assessments via common consumer electronics lowers entry barriers for sophisticated monitoring solutions. The diagnostic strength of these acoustic tools is backed by robust data; a study published in Healthcare in March 2025 reported that a machine learning model analyzing specific speech phonemes achieved a classification accuracy of 98.7% in determining asthma status.

Key Market Players

• Philips Healthcare
• ResMed Inc.
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc
• Novartis AG
• AstraZeneca plc
• Merck & Co., Inc.
• Propeller Health
• Adherium Limited
• Cohero Health, Inc.

Report Scope

In this report, the Global Asthma Warning Sensors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Warning Sensors Market, By Type

• Wearable v/s Non-Wearable

Asthma Warning Sensors Market, By Technology

• AI
• IoT
• Machine Learning
• Others

Asthma Warning Sensors Market, By Parameter Measured

• FEV1 v/s Peak Flow

Asthma Warning Sensors Market, By End User

• Hospitals & Clinics v/s Homecare

Asthma Warning Sensors Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Warning Sensors Market.

Available Customizations:

Global Asthma Warning Sensors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Asthma Warning Sensors Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Wearable v/s Non-Wearable)
  • 5.2.2. By Technology (AI, IoT, Machine Learning, Others)
  • 5.2.3. By Parameter Measured (FEV1 v/s Peak Flow)
  • 5.2.4. By End User (Hospitals & Clinics v/s Homecare)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Asthma Warning Sensors Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Parameter Measured
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Asthma Warning Sensors Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Parameter Measured
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Asthma Warning Sensors Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Parameter Measured
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Asthma Warning Sensors Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Parameter Measured
      • 6.3.3.2.4. By End User

7. Europe Asthma Warning Sensors Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Parameter Measured
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Asthma Warning Sensors Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Parameter Measured
      • 7.3.1.2.4. By End User
  • 7.3.2. France Asthma Warning Sensors Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Parameter Measured
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Asthma Warning Sensors Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Parameter Measured
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Asthma Warning Sensors Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Parameter Measured
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Asthma Warning Sensors Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Parameter Measured
      • 7.3.5.2.4. By End User

8. Asia Pacific Asthma Warning Sensors Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Parameter Measured
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Asthma Warning Sensors Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Parameter Measured
      • 8.3.1.2.4. By End User
  • 8.3.2. India Asthma Warning Sensors Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Parameter Measured
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Asthma Warning Sensors Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Parameter Measured
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Asthma Warning Sensors Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Parameter Measured
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Asthma Warning Sensors Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Parameter Measured
      • 8.3.5.2.4. By End User

9. Middle East & Africa Asthma Warning Sensors Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Parameter Measured
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Asthma Warning Sensors Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Parameter Measured
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Asthma Warning Sensors Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Parameter Measured
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Asthma Warning Sensors Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Parameter Measured
      • 9.3.3.2.4. By End User

10. South America Asthma Warning Sensors Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Parameter Measured
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Asthma Warning Sensors Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Parameter Measured
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Asthma Warning Sensors Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Parameter Measured
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Asthma Warning Sensors Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Parameter Measured
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Asthma Warning Sensors Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Philips Healthcare
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. ResMed Inc.
• 15.3. Teva Pharmaceutical Industries Ltd.
• 15.4. GlaxoSmithKline plc
• 15.5. Novartis AG
• 15.6. AstraZeneca plc
• 15.7. Merck & Co., Inc.
• 15.8. Propeller Health
• 15.9. Adherium Limited
• 15.10. Cohero Health, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer